Kees van de Beek

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER—GENITO-URINARY GROUP PHASE III TRIAL (30906)

Theo M. de Reijke, Karl H. Kurth, Richard Sylvester et al. · The Journal of Urology · 2005 · 123 citations

Medicine, Oncology, Urology +12

Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?

Ben Vanneste, Madelon Pijls-Johannesma, Lien Van De Voorde et al. · Radiotherapy and Oncology · 2015 · 64 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making

Anshu Ankolekar, Ben Vanneste, Esther Bloemen‐van Gurp et al. · BMC Medical Informatics and Decision Making · 2019 · 49 citations · Full text

Computing, Health Informatics, Oncology +17

Dynamics of rectal balloon implant shrinkage in prostate VMAT

Ben Vanneste, Yvonka van Wijk, Ludy Lutgens et al. · Strahlentherapie und Onkologie · 2017 · 24 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Implantation of a biodegradable rectum balloon implant: Tips, Tricks and Pitfalls

Ben Vanneste, Kees van de Beek, Ludy Lutgens et al. · International braz j urol · 2017 · 20 citations · Full text

Medicine, Radiation Oncology, Surgery +13